The relationship between cardiac resynchronization therapy and diastolic function

Gregory F Egnaczyk1, Eugene S Chung

  • 1The Heart and Vascular Center at The Christ Hospital, 2123 Auburn Ave, Ste 137, Cincinnati, OH, 45219, USA.

Insights

Cardiac resynchronization therapy (CRT) may improve diastolic function, particularly in patients with elevated filling pressures. However, CRT

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Technology

Background:

  • Cardiac resynchronization therapy (CRT) is known to improve systolic function and clinical outcomes.
  • The impact of CRT on diastolic function remains less understood, with existing data showing conflicting results.

Purpose of the Study:

  • To review and synthesize existing literature on the effects of CRT on diastolic function.
  • To identify trends and patient characteristics associated with diastolic improvements following CRT.

Main Methods:

  • Systematic review of studies investigating CRT and diastolic function parameters.
  • Analysis of echocardiographic data including pulse wave and tissue Doppler, timing, and deformation measurements.
  • Correlation of diastolic changes with baseline patient characteristics and systolic function improvements.

Main Results:

  • Conflicting data exists, but general trends suggest CRT may improve certain diastolic parameters.
  • Patients with baseline elevated filling pressures are more likely to show improvement in this specific parameter.
  • Intrinsic relaxation is generally not significantly affected by CRT; changes in diastolic properties are often linked to improvements in systolic function.

Conclusions:

  • CRT's effects on diastolic function are complex and often secondary to improvements in systolic function.
  • Current CRT strategies do not specifically target diastolic asynchrony due to unclear relationships and technical limitations.
  • Further research is needed to understand and potentially target diastolic dysfunction in the context of CRT.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598